3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
1
Rectal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Oropharyngeal Neoplasms
1
Lymphoma, Follicular
1
Leukemia, Hairy Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Burkitt Lymphoma
1
Anus Neoplasms
1
Interventions
fludarabine phosphate
2
fludarabine
2
blinatumomab
2
Radiotherapy
2
Cyclophosphamide
2
trastuzumab deruxtecan
1
tislelizumab
1
tisagenlecleucel
1
talquetamab
1
obinutuzumab
1
Trastuzumab
1
Monatide (IMS 3015)
1
Maintenance
1
HMPL-013
1
Cetuximab
1
Blood Specimen Collection
1
Biological Assay
1
Ado-Trastuzumab Emtansine
1
AP 1903 reagent
1
ALT-803
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasm, Residual
×
Diphenhydramine
×
30 days
×
Clear all
No trials found.